[go: up one dir, main page]

FI971403L - Förfarande för framställning av stegrade antigeniska enteriska bakterier och vaccin innehållande desamma - Google Patents

Förfarande för framställning av stegrade antigeniska enteriska bakterier och vaccin innehållande desamma Download PDF

Info

Publication number
FI971403L
FI971403L FI971403A FI971403A FI971403L FI 971403 L FI971403 L FI 971403L FI 971403 A FI971403 A FI 971403A FI 971403 A FI971403 A FI 971403A FI 971403 L FI971403 L FI 971403L
Authority
FI
Finland
Prior art keywords
vaccines containing
enteric bacteria
producing enhanced
enhanced antigenic
antigenic
Prior art date
Application number
FI971403A
Other languages
English (en)
Finnish (fi)
Other versions
FI971403A7 (sv
FI971403A0 (sv
Inventor
John L Pace
Richard I Walker
Steven M Frey
Original Assignee
Microcarb Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/538,543 external-priority patent/US5681736A/en
Application filed by Microcarb Inc filed Critical Microcarb Inc
Publication of FI971403A0 publication Critical patent/FI971403A0/sv
Publication of FI971403L publication Critical patent/FI971403L/sv
Publication of FI971403A7 publication Critical patent/FI971403A7/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/045—Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI971403A 1994-10-05 1995-10-04 Förfarande för framställning av stegrade antigeniska enteriska bakteri er och vaccin innehållande desamma FI971403A7 (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31840994A 1994-10-05 1994-10-05
US08/538,543 US5681736A (en) 1994-10-05 1995-10-03 Methods for producing enhanced antigenic shigella bacteria and vaccines comprising same
US08/538,545 US5679564A (en) 1994-10-05 1995-10-03 Methods for producing enhanced antigenic campylobacter bacteria and vaccines
PCT/US1995/013196 WO1996011258A1 (en) 1994-10-05 1995-10-04 Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same

Publications (3)

Publication Number Publication Date
FI971403A0 FI971403A0 (sv) 1997-04-04
FI971403L true FI971403L (sv) 1997-06-04
FI971403A7 FI971403A7 (sv) 1997-06-04

Family

ID=27405987

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971403A FI971403A7 (sv) 1994-10-05 1995-10-04 Förfarande för framställning av stegrade antigeniska enteriska bakteri er och vaccin innehållande desamma

Country Status (16)

Country Link
EP (1) EP0804542A4 (sv)
JP (1) JP3394047B2 (sv)
CN (1) CN1168693A (sv)
AU (1) AU704283B2 (sv)
BR (1) BR9509276A (sv)
CA (1) CA2202027A1 (sv)
CZ (1) CZ104397A3 (sv)
FI (1) FI971403A7 (sv)
HU (1) HUT77876A (sv)
IL (1) IL115521A0 (sv)
MX (1) MX9702431A (sv)
NO (1) NO971519L (sv)
NZ (1) NZ295907A (sv)
PL (1) PL182700B1 (sv)
SG (2) SG73510A1 (sv)
WO (1) WO1996011258A1 (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ295877A (en) * 1994-10-05 1999-03-29 Antex Biolog Inc A vaccine comprising the helicobacter bacterium and its use
US20080175856A1 (en) * 2003-05-30 2008-07-24 Intercell Ag Enterococcus Antigens
US20100074846A1 (en) * 2006-03-17 2010-03-25 Ellis John A Campylobacter Vaccines and Methods of use
JP5398527B2 (ja) * 2007-05-28 2014-01-29 北里第一三共ワクチン株式会社 パラ百日咳菌全菌体ワクチン組成物
CN107513553B (zh) * 2017-09-18 2021-05-18 江南大学 一种筛选具有拮抗空肠弯曲杆菌感染功能的乳酸菌的方法
CN109633151B (zh) * 2018-12-26 2022-03-11 西北农林科技大学 一种肠炎沙门氏菌检测方法、试纸条及应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993005811A1 (en) * 1991-09-18 1993-04-01 Amgen Inc. A hepatitis b vaccine formulation incorporating a bile acid salt

Also Published As

Publication number Publication date
JP3394047B2 (ja) 2003-04-07
IL115521A0 (en) 1996-06-18
SG73509A1 (en) 2000-06-20
EP0804542A1 (en) 1997-11-05
CZ104397A3 (cs) 1998-06-17
EP0804542A4 (en) 1998-10-28
PL319580A1 (en) 1997-08-18
NZ295907A (en) 1999-04-29
NO971519L (no) 1997-05-27
NO971519D0 (no) 1997-04-03
FI971403A7 (sv) 1997-06-04
CN1168693A (zh) 1997-12-24
MX9702431A (es) 1998-05-31
BR9509276A (pt) 1997-11-18
WO1996011258A1 (en) 1996-04-18
FI971403A0 (sv) 1997-04-04
AU3956195A (en) 1996-05-02
HUT77876A (hu) 1998-09-28
PL182700B1 (pl) 2002-02-28
SG73510A1 (en) 2000-06-20
JPH10507347A (ja) 1998-07-21
AU704283B2 (en) 1999-04-15
CA2202027A1 (en) 1996-04-18

Similar Documents

Publication Publication Date Title
FI955727L (sv) Förfarande och anordning för framställning av liposomer
FI971530A7 (sv) Lipas, mikroorganism som producerar detta, förfarande för framställnin g av lipaset och användning av detta
FI953731L (sv) Förfarande för odling av PRRS-virus och användning därav i vacciner
FI960948A7 (sv) Förpackning och förfarande för produktion av förpackningen
FI955362A0 (sv) Symmetreringsanordning och förfarande för konstruering därav
FI951305A7 (sv) Medicinskt material och förfarande för framställning därav
FI951184A7 (sv) Deg innefattande sammansättning och förfarande för dess framställning
FI973378A0 (sv) Anordning och förfarande
HU9602310D0 (en) Urease-based vaccine and treatment for helicobacter infection
EP0555366A4 (en) Bacterial attenuation method and vaccine
FI922854L (sv) Förfarande och anordning för framställning av fibrer
NO950205D0 (no) Framgangsmåte og anordning for framstilling av emballasje
FI962486A7 (sv) Förpackning och förfarande samt anordning för dess framställning
FI964083A7 (sv) Fusionerbara liposomer och metoder för deras framställning och användning
FI961937L (sv) Dryck och förfarande för dess framställning
FI930266L (sv) Vaterit och förfarande för dess framställning
FI916112L (sv) Sliphjälpmedel och förfarande för slipning användande detsamma
FI953524A0 (sv) Förfarande och anordning för framställning av glasvaror med öppen mynning
FI941414A7 (sv) Förfarande och anordning för framställning av bioproteiner
FI971403L (sv) Förfarande för framställning av stegrade antigeniska enteriska bakterier och vaccin innehållande desamma
DE69515600D1 (de) Synchronisationsvorrichtung und -verfahren
FI971402L (sv) Förfarande för framställning av stegrade antigeniska Helicobacter arter och vaccin innehållande desamma
FI956239L (sv) Förfarande för framställning av tydligt märkta föremål som består av silikon samt deras användning
FI911989A7 (sv) Blankett och förfarande
DE69312971D1 (de) Methode und Mittel zur Herstellung von Gehrungsfugen

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: ANTEX BIOGICS, INC.

MA Patent expired